Chemtrade's North Van injunction: a new legal overhang on a capital plan timed to the cycle

Q2 call surfaces a judicial review of the City Council decision plus a confirmed Ultrapure ramp; sulphur and caustic remain swing factors.

CHE-UN.TO · Earnings Call · 2026-08-13

The Legal Overhang

The headline change for Chemtrade this quarter is the emergence of a judicial review over the City Council's decision on the North Vancouver facility. judicial review and the related injunction are new — they appear only in the latest quarter's keyword trajectory, a departure from the prior calls that focused on rezoning discussions. Management confirmed the company will join the action to defend the facility's operating license. As Scott Rook explained, “the applications of judicial review is actually a public document that you can look at” — Scott Rook, Chief Executive Officer · 2026-08-13, and the company intends to intervene. The capital plan — $75–105 million over roughly four years, concentrated in 2028 and 2030 — is now contingent on the hearing outcome. Rook noted: “if the decision is favorable for that, that would still work out for us with the plan that we had to deploy capital in '28 and '30.” — Scott Rook, Chief Executive Officer · 2026-08-13 This legal overhang is significant because it directly impacts North Van spending, which is tied to turnaround cycles and new liquefication capabilities on the company's own land. The prior call in May had already described active negotiations with the district; the jump from negotiation to litigation is a qualitative shift. In the May call, Scott had said, “we have been having active negotiations with the district, and we did modify our earlier proposal.” — Scott Rook, Chief Executive Officer · 2026-05-12 Now the company is facing a judicial review that could delay the entire program.

Commodity Swings and the Sulphur Peak

The other major theme is the continued volatility in raw materials, particularly sulphur and caustic. Sulphur has been elevated for several quarters, but management now believes it is at or near a peak. Rook put it plainly:

So sulphur, as we know, has risen. It's jumped up considerably close to all-time highs. And so the outlook for sulphur is that -- the outlook is that it's at its peak and then at some point here before long, it's going to come down.
Scott Rook, Chief Executive Officer · 2026-08-13

This is a recurring theme — in the May call, Rohit noted they had factored in higher sulphur and aluminum costs. “we have taken into account the higher sulfur and other input costs like aluminum that has been factored in.” — Rohit Bhardwaj, Chief Financial Officer · 2026-05-12 The key difference now is the explicit expectation that sulfur price will recede, which should support Water Solutions margins as annual contracts reprice lower over time. Caustic remains the swing factor. Management discussed the post-Iran price spike and the subsequent fall due to Chinese PVC production. The outlook is for a gradual increase, with caustic prices expected to recover modestly. This is consistent with the prior call's reliance on the CMA outlook, but the tone here is more cautious: Rook had said earlier, “caustic soda is lower. It's lower than our assumptions, what we put in the assumptions.” — Scott Rook, Executive (likely CFO or COO) · 2026-02-27 Now they are assuming stabilization and a modest uptick, though the path remains uncertain.

Ultrapure Ramp and the Second-Half Path

A confirmed positive is the Ultrapure ramp. Rook stated: “we are ramping up in the second half of this year, sales to 2 of advanced node chip producers in North America.” — Scott Rook, Chief Executive Officer · 2026-08-13 This puts the Cairo facility on schedule to fill up over the next couple of years, as management had indicated in earlier quarters. The company also confirmed that EBITDA guidance implies a flat year, with the second-half recovery driven by the EC segment and continued strength in acid. This is a company-specific signal that the organic growth story is on track, even as the legal and commodity uncertainties create headwinds. The keyword "chip producers" (id=7045336a69) is new this quarter, underscoring the strategic pivot toward high-purity acid for semiconductor fabs. The ramp is not dependent on the legal outcome, so it provides some insulation.

Capital Allocation and Leverage

The company also disclosed that it has tempered its share buyback pace, citing the increased leverage from the Polytech acquisition. With leverage now at 2.5x, management is balancing buybacks against organic growth and distribution policy. This is a pragmatic stance, but it means the NCIB is less of a driver than in prior quarters. The key variable remains the North Van injunction—if the hearing slips beyond 2027, the capital spend could be stretched further, but the company's plan to do the majority of work in 2028 and 2030 still appears feasible if the legal process is resolved favorably. Overall, the quarter's narrative is defined by a new legal risk layered onto an already cyclical commodity environment. The confirmation of the Ultrapure ramp is a bright spot, but the market will be watching the hearing timeline and the evolution of sulphur and caustic prices. This is a company-unique story—no other reporter in the recent window mentioned judicial review or North Van—and it carries enough specificity to warrant attention.